Tg Therapeutics (TGTX) Other Non Operating Income (2009 - 2026)
Tg Therapeutics (TGTX) recorded Other Non Operating Income of $5.13 million in Q2 2026, up 83.7% from $2.79 million a year earlier.
Tg Therapeutics (TGTX) Other Non Operating Income (2009 - 2026) Analysis & Trends
On a TTM basis, Tg Therapeutics' Other Non Operating Income came in at $376,000 as of Jun 30, 2026, down 96.8% year-over-year; for FY2025, it came in at $10.79 million, up 40.3% from FY2024.
- Annual Other Non Operating Income has increased for four straight years, with a four-year compound annual growth rate of 47.1% (FY2021 to FY2025).
- Across earlier years, Other Non Operating Income came in at $7.69 million in FY2024 (+52.5%), $5.04 million in FY2023 (+7.4%), $4.7 million in FY2022 (+103.5%) and $2.31 million in FY2021.
- The Q2 2026 figure is the highest quarterly Other Non Operating Income in data going back to Q2 2011.
- On a year-over-year basis, Other Non Operating Income rose in five of the last seven quarters, with growth averaging 86.3%.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 309.4% in Q1 2025, against a decline of 55.9% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$9.15 million (Q1 2026), $1.13 million (Q4 2025) and $3.27 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Tg Therapeutics | 9.71 Bn | 8.96 Bn | 217.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.78 Mn |
| Jun 30, 2026 | 5.13 Mn |
| Mar 31, 2026 | -6.77 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 3.27 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 880,000.00 |
| Dec 31, 2023 | 890,000.00 |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 691,000.00 |
| Mar 31, 2023 | 604,000.00 |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 793,000.00 |
| Jun 30, 2019 | 408,000.00 |
| Mar 31, 2019 | 616,000.00 |
| Dec 31, 2018 | -24,000.00 |
Tg Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();